Supplemental material
Journal of Enzyme Inhibition and Medicinal Chemistry
Volume 38, 2023 - Issue 1
Research Paper
Novel multi-target ligands of dopamine and serotonin receptors for the treatment of schizophrenia based on indazole and piperazine scaffolds–synthesis, biological activity, and structural evaluation
Piotr Stępnickia Department of Synthesis and Chemical Technology of Pharmaceutical Substances, Faculty of Pharmacy, Medical University of Lublin, Lublin, PolandCorrespondence[email protected]
https://orcid.org/0000-0002-3470-8248View further author information
https://orcid.org/0000-0002-3470-8248View further author information, Olga Wronikowska-Denysiukb Independent Laboratory of Behavioral Studies, Chair of Biomedical Sciences, Faculty of Biomedicine, Medical University of Lublin, Lublin, Polandhttps://orcid.org/0000-0002-9553-3664View further author information
https://orcid.org/0000-0002-9553-3664View further author information, Agata Ziębaa Department of Synthesis and Chemical Technology of Pharmaceutical Substances, Faculty of Pharmacy, Medical University of Lublin, Lublin, Polandhttps://orcid.org/0000-0002-8515-7482View further author information
https://orcid.org/0000-0002-8515-7482View further author information, Katarzyna M. Targowska-Dudac Department of Biopharmacy, Faculty of Pharmacy, Medical University of Lublin, Lublin, Polandhttps://orcid.org/0000-0003-4871-0848View further author information
https://orcid.org/0000-0003-4871-0848View further author information, Agata Bartyzeld Department of General and Coordination Chemistry and Crystallography, Institute of Chemical Sciences, Faculty of Chemistry, Maria Curie-Sklodowska University in Lublin, Lublin, Polandhttps://orcid.org/0000-0003-3765-6997View further author information
https://orcid.org/0000-0003-3765-6997View further author information, Martyna Z. Wróbele Department of Drug Technology and Pharmaceutical Biotechnology, Faculty of Pharmacy, Medical University of Warsaw, Warsaw, Polandhttps://orcid.org/0000-0001-6201-4756View further author information
https://orcid.org/0000-0001-6201-4756View further author information, , Klaudia Szałajf Department of Bioanalytics, Faculty of Biomedicine, Medical University of Lublin, Lublin, Polandhttps://orcid.org/0000-0003-4962-2997View further author information
https://orcid.org/0000-0003-4962-2997View further author information, , , Barbara Budzyńskab Independent Laboratory of Behavioral Studies, Chair of Biomedical Sciences, Faculty of Biomedicine, Medical University of Lublin, Lublin, Polandhttps://orcid.org/0000-0001-5917-9285View further author information
https://orcid.org/0000-0001-5917-9285View further author information, Emilia Fornalf Department of Bioanalytics, Faculty of Biomedicine, Medical University of Lublin, Lublin, Polandhttps://orcid.org/0000-0002-0503-0706View further author information
https://orcid.org/0000-0002-0503-0706View further author information, Jadwiga Turłoe Department of Drug Technology and Pharmaceutical Biotechnology, Faculty of Pharmacy, Medical University of Warsaw, Warsaw, Polandhttps://orcid.org/0000-0003-3575-8631View further author information
https://orcid.org/0000-0003-3575-8631View further author information, Marián Castrog Department of Pharmacology, Center for Research in Molecular Medicine and Chronic Diseases (CIMUS), Universidade de Santiago de Compostela, Santiago de Compostela, Spain;h Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), Santiago de Compostela, Spainhttps://orcid.org/0000-0002-4732-1966View further author information
https://orcid.org/0000-0002-4732-1966View further author information & show all